You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 9,775,946


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,775,946
Title:Unified drug mixer and dispenser
Abstract: A unified dispenser for holding, mixing, and dispensing a drug includes a housing holding a diluent reservoir, a drug reservoir, and a tubing set connecting and defining a fluid communication path therebetween. A first occlusion is at the diluent reservoir, and a second occlusion is at the drug reservoir. In a storage state of the dispenser, the first and second occlusions are entirely encased within the housing and occlude the fluid communication path. First and second pull assemblies extend outside the housing. The first and second pull assemblies are coupled to the first and second occlusions, respectively, so that removal of the first and second pull assemblies removes the first and second occlusions and joins the diluent reservoir to the drug reservoir in fluid communication through the tubing set, thereby arranging the dispenser from the storage state to a use state.
Inventor(s): McNall, III; Ralph I. (Belmont, CA), Donze; Thomas T. (South San Francisco, CA), MacDonell; Andrew M. (San Francisco, CA), Joshi; Serena (San Francisco, CA)
Assignee:
Application Number:15/041,157
Patent Claims:1. A unified dispenser for holding, mixing, and dispensing a drug, the dispenser comprising: a housing holding a diluent reservoir for containing a diluent, a drug reservoir for containing a drug, and a tubing set connecting and defining a fluid communication path therebetween; a first aseptic connector encasing a first occlusion, and a second aseptic connector encasing a second occlusion; the first aseptic connector is located at the diluent reservoir and the second aseptic connector is located at the drug reservoir; in a storage state of the dispenser, the first and second occlusions are entirely encased within the housing and occlude the fluid communication path; and first and second pull assemblies, each extending to outside the housing; wherein the first and second pull assemblies extend into the first and second aseptic connectors and include the first and second occlusions, respectively, so that removal of the first and second pull assemblies removes the first and second occlusions from the first and second aseptic connectors, respectively, joins the diluent reservoir to the tubing set in fluid communication, joins the drug reservoir to the tubing set in fluid communication, and joins the diluent reservoir to the drug reservoir in fluid communication through the tubing set, thereby arranging the dispenser from the storage state to a use state.

2. The dispenser of claim 1, wherein removal of one of the first and second occlusions energizes the dispenser.

3. The dispenser of claim 1, further comprising: a pump assembly; and energy storage means; wherein removal of one of the first and second occlusions electrically couples the pump assembly to the energy storage means.

4. The dispenser of claim 3, wherein: within the use state, the dispenser further has a mix state and a dispense state; in the mix state, the pump assembly operates in a first direction to mix the diluent with the drug; and in the dispense state, the pump assembly operates in a second direction different from the first direction to dispense a mixture of the diluent and the drug.

5. The dispenser of claim 1, further comprising: the first aseptic connector comprises an upper first aseptic connector mated to a lower first aseptic connector; and the second aseptic connector comprises an upper second aseptic connector mated to a lower second aseptic connector.

6. The dispenser of claim 5, wherein: the upper first aseptic connector is coupled to the diluent reservoir, the lower first aseptic connector is coupled to the tubing set, the upper second aseptic connector is coupled to the drug reservoir, and the lower second aseptic connector is coupled to the tubing set; the first occlusion comprises an upper first ribbon and a lower first ribbon in the first aseptic connector; the second occlusion comprises an upper second ribbon and a lower second ribbon in the second aseptic connector; and in the storage state, the upper first, lower first, upper second, and lower second aseptic connectors are occluded by the upper first, lower first, upper second, and lower second ribbons, respectively.

7. The dispenser of claim 6, wherein: in the storage state, the upper and lower first ribbons are against each other between the upper and lower first aseptic connectors; in the storage state, the upper and lower second ribbons are against each other between upper and lower second aseptic connectors; removal of the first pull assembly defines the upper and lower first aseptic connectors as a diluent aseptic connector assembly, having a sterile bore therethrough from the diluent reservoir to the tubing set; and removal of the second pull assembly defines the upper and lower second aseptic connectors as a drug aseptic connector assembly, having a sterile bore therethrough from the drug reservoir to the tubing set.

8. The dispenser of claim 7, wherein the first and second aseptic connectors each include valve means for controlling a directional flow of the diluent through the first and second aseptic connectors.

9. The dispenser of claim 1, wherein removal of the first and second occlusions is irreversible.

10. A unified dispenser for holding, mixing, and dispensing a drug, the dispenser comprising: a housing holding energy storage means, a pump assembly, a diluent reservoir, a drug reservoir, and a tubing set connecting and defining a fluid communication path between the diluent reservoir and the drug reservoir; a first aseptic connector encasing a first occlusion, and a second aseptic connector encasing a second occlusion, the first and second aseptic connectors disposed within the housing; the first aseptic connector is located at the diluent reservoir and the second aseptic connector is located at the drug reservoir; in a storage state of the dispenser, the first and second occlusions are entirely encased within the housing and occlude the fluid communication path; and first and second pull assemblies, each extending to outside the housing, configured to remove the first and second occlusions, respectively; wherein removal of the first and second pull assemblies removes the first and second occlusions from the first and second aseptic connectors, respectively, joins the diluent reservoir to the tubing set in fluid communication, joins the drug reservoir to the tubing set in fluid communication, joins the diluent reservoir to the drug reservoir in fluid communication through the tubing set, and electrically couples the pump assembly to the energy storage means, thereby arranging the dispenser from the storage state to a use state.

11. The dispenser of claim 10, wherein removal of one of the first and second occlusions energizes the dispenser.

12. The dispenser of claim 10, wherein removal of the first and second pull assemblies joins the diluent reservoir to the drug reservoir in fluid communication through the tubing set and electrically couples the pump assembly to the energy storage means simultaneously.

13. The dispenser of claim 10, further comprising: the first aseptic connector comprises an upper first aseptic connector mated to a lower first aseptic connector; and the second aseptic connector comprises an upper second aseptic connector mated to a lower second aseptic connector.

14. The dispenser of claim 13, wherein: the upper first aseptic connector is coupled to the diluent reservoir, the lower first aseptic connector is coupled to the tubing set, the upper second aseptic connector is coupled to the drug reservoir, and the lower second aseptic connector is coupled to the tubing set; the first occlusion comprises an upper first ribbon and a lower first ribbon in the first aseptic connector; the second occlusion comprises an upper second ribbon and a lower second ribbon in the second aseptic connector; and in the storage state, the upper first, lower first, upper second, and lower second aseptic connectors are occluded by the upper first, lower first, upper second, and lower second ribbons, respectively.

15. The dispenser of claim 14, wherein: in the storage state, the upper and lower first ribbons are against each other between the upper and lower first aseptic connectors; in the storage state, the upper and lower second ribbons are against each other between upper and lower second aseptic connectors; removal of the first pull assembly defines the upper and lower first aseptic connectors as a diluent aseptic connector assembly, having a sterile bore therethrough from the diluent reservoir to the tubing set; and removal of the second pull assembly defines the upper and lower second aseptic connectors as a drug aseptic connector assembly, having a sterile bore therethrough from the drug reservoir to the tubing set.

16. The dispenser of claim 10, wherein: within the use state, the dispenser further has a mix state and a dispense state; in the mix state, the pump assembly operates in a first direction to mix the diluent with the drug; and in the dispense state, the pump assembly operates in a second direction different from the first direction to dispense a mixture of the diluent and the drug.

17. A unified dispenser for holding, mixing, and dispensing a drug, the dispenser comprising: a housing holding energy storage means, a pump assembly, a diluent reservoir containing a diluent, a drug reservoir containing a drug, a tubing set connecting and defining a fluid communication path between the diluent reservoir and the drug reservoir, and an administration line; a first aseptic connector encasing a first occlusion, and a second aseptic connector encasing a second occlusion; the first aseptic connector is located at the diluent reservoir and the second aseptic connector is located at the drug reservoir; the first and second occlusions are entirely encased within the housing; a storage state, a mix state, and a dispense state of the dispenser; in the storage state of the dispenser, the first and second occlusions occlude the fluid communication path, the drug is maintained in the drug reservoir by and against the second occlusion, and the diluent is maintained in the diluent reservoir by and against the first occlusion; in the mix state of the dispenser, the first and second occlusions are removed, and the pump assembly communicates the diluent from the diluent reservoir to the drug reservoir to mix the diluent with the drug reservoir; and in the dispense state of the dispenser, the pump assembly dispenses a mixture of the diluent and the drug out of the administration line.

18. The dispenser of claim 17, wherein removal of the first and second occlusions arranges the dispenser out the storage state in preparation for the mix state.

19. The dispenser of claim 17, wherein the dispenser is configured to irreversibly move from the storage state to the mix state.

20. The dispenser of claim 17, wherein removal of the first and second occlusions electrically couples the pump assembly to the energy storage means.

21. The dispenser of claim 17, further comprising: the first aseptic connector comprises an upper first aseptic connector mated to a lower first aseptic connector; and the second aseptic connector comprises an upper second aseptic connector mated to a lower second aseptic connector.

22. The dispenser of claim 21, wherein: the upper first aseptic connector is coupled to the diluent reservoir, the lower first aseptic connector is coupled to the tubing set, the upper second aseptic connector is coupled to the drug reservoir, and the lower second aseptic connector is coupled to the tubing set; the first occlusion comprises an upper first ribbon and a lower first ribbon in the first aseptic connector; the second occlusion comprises an upper second ribbon and a lower second ribbon in the second aseptic connector; and in the storage state, the upper first, lower first, upper second, and lower second aseptic connectors are occluded by the upper first, lower first, upper second, and lower second ribbons, respectively.

23. The dispenser of claim 22, wherein: in the storage state, the upper and lower first ribbons are against each other between the upper and lower first aseptic connectors; in the storage state, the upper and lower second ribbons are against each other between upper and lower second aseptic connectors; removal of the first pull assembly defines the upper and lower first aseptic connectors as a diluent aseptic connector assembly, having a sterile bore therethrough from the diluent reservoir to the tubing set; and removal of the second pull assembly defines the upper and lower second aseptic connectors as a drug aseptic connector assembly, having a sterile bore therethrough from the drug reservoir to the tubing set.

24. The dispenser of claim 17, wherein: in the mix state, the pump assembly operates in a first direction o mix the diluent with the drug; and in the dispense state, the pump assembly operates in a second direction different from the first direction to dispense a mixture of the diluent and the drug.

25. The dispenser of claim 17, wherein the drug is selected from the group consisting of vancomycin, cefazolin, cefoxitin, ceftriaxone, linezolid, ampicillin, azithromycin, cefepime, veftazidime, cefuroxime, oxacillin, meropenem, cefotaxime, gentamicin, tobramycin, cimetidine, cefazolin, cefoxitin, ampicillin, clindamycin, cefepime, caspofungin, cefotetan, meropenem, tobramycin, primaxin, quinupristin and dalfopristin, rifampin, cladribine, thiotepa, taliglucerase alfa, velaglucerase alfa, ivig, hemin, trastuzumab, cyclophosphamide, lyophilized cytoxan, endoxan, procytox, cycloblastin, dacarbazine, plicamycin, trimetrexate, mitomycin, sargramostim, bendamustine, bortezomib, gemtuzumab ozogamicin, fludarabine, gemcitabine, carmustine, dacarbazine, dexrazoxane, doxorubicin, etoposide, ifosfamide, and pembrolizumab.

26. The dispenser of claim 17, wherein the drug is selected from the group consisting of dolasetron, labetolol, dobutamine, bevacizumab, filgrastim, panitumumab, dacarbazine, docetaxel, mitoxantrone, sargramostim, teniposide, rituximab, cetuximab, gemtuzumab ozogamicin, irinotecan, oxaliplatin, paclitaxel, topotecan, vinorelbine, carboplatin, cisplatin, dacarbazine, doxorubicin, idarubicin, oxaliplatin, nivolumab, docetaxel, paclitaxel, ferumoxytol, dexmedetomedine, taxanes, and cabazitaxel.

27. The dispenser of claim 17, wherein the drug is selected from the group consisting of pidilizumab, ipilimumab, anti-PD1, anti-PD-L1, durvalumab, avelumab, atezolizumab, anti-OX40, anti-4-1BB, anti-GITR, anti-TIM2, anti-LAG3, anti-TNFRSF25, anti-ICOS, light-activated drugs for tumor ablation, anti-EGFR, anti-TGFbeta, IDO and TDO inhibitors, kynurenine inhibitors, and cleavage enzymes, inhibitors of the tryptophan metabolic pathway, anti-phosphatidylserine antibody-drug conjugates containing a tumor-targeting moiety and a cytotoxic moiety, bi-specific antibodies or proteins containing targets present on tumor cells and T cells, or on tumor cells and B cells, or on tumor cells and other lymphocytes, or on T cells and antigen-presenting cells, anti-VEGF, BTK inhibitors, RAS inhibitors, MET inhibitors, and combinations of at least two of the above agents.

Details for Patent 9,775,946

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Pfizer Inc. ELELYSO taliglucerase alfa For Injection 022458 05/01/2012 ⤷  Try a Trial 2039-02-26
Takeda Pharmaceuticals U.s.a., Inc. VPRIV velaglucerase alfa For Injection 022575 02/26/2010 ⤷  Try a Trial 2039-02-26
Recordati Rare Diseases, Inc. PANHEMATIN hemin for injection For Injection 101246 07/20/1983 ⤷  Try a Trial 2039-02-26
Amgen, Inc. NEUPOGEN filgrastim Injection 103353 02/20/1991 ⤷  Try a Trial 2039-02-26
Amgen, Inc. NEUPOGEN filgrastim Injection 103353 06/28/2000 ⤷  Try a Trial 2039-02-26
Partner Therapeutics, Inc. LEUKINE sargramostim For Injection 103362 03/05/1991 ⤷  Try a Trial 2039-02-26
Partner Therapeutics, Inc. LEUKINE sargramostim Injection 103362 03/05/1991 ⤷  Try a Trial 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.